-
2 months ago | 
healio.com | Rob Volansky |Shenaz Bagha |Jeffrey A Sparks |Kevin L. Winthrop
Inconsistent messaging and evolving recommendations surrounding COVID-19 vaccination protocols may have contributed to both hesitancy and fatigue regarding vaccines among patients, according to experts.
-
Aug 5, 2024 | 
ajmc.com | Bryan Garcia |Bryan García |Ryan Haumschild |Margaret Johnson |Rebecca Keith |Diego J. Maselli | +4 more
AbstractNon–cystic fibrosis bronchiectasis is a chronic inflammatory airway disease that results in permanent lung damage and can correlate with considerable clinical and economic burden. There are gaps in knowledge surrounding bronchiectasis, for which there are no published US-based treatment guidelines or FDA-approved therapies. Given the current challenges and gaps in care, the authors of this article convened for an AJMC® roundtable in March 2024.
-
May 23, 2024 | 
ard.bmj.com | Gerd R Burmester |Jacques-Eric Gottenberg |Roberto Caporali |Kevin L. Winthrop
Antirheumatic AgentsArthritis, RheumatoidTherapeuticsData availability statementData are available upon reasonable request. Anonymised individual patient data will be shared upon request for research purposes, dependent upon the nature of the request, the merit of the proposed research and the availability of the data and their intended use. The full data sharing policy for Gilead Sciences, Inc., can be found at https://www.gilead.com/about/ethics-and-code-of-conduct/policies.
-
May 15, 2024 | 
ard.bmj.com | Jin Kyun Park |Eun Bong Lee |Kevin L. Winthrop
Introduction Patients with autoimmune inflammatory rheumatic diseases (AIIRD) are at higher risk for serious infections due to underlying immune dysfunction, treatment-associated immunosuppression or both.1–3 Although these patients should receive the recommended vaccines, the vaccine coverage in this population remains suboptimal.4 5 Factors contributing to vaccination hesitance include concerns about disseminated infections from live-attenuated vaccines, the potential risk of exacerbating...
-
Feb 27, 2024 | 
ard.bmj.com | Jin Kyun Park |Eun Bong Lee |Kevin L. Winthrop
What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Jan 12, 2024 | 
healio.com | Rob Volansky |Shenaz Bagha |Kevin L. Winthrop
You've successfully added Rheumatology: Infection to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Jan 4, 2024 | 
emjreviews.com | Kevin L. Winthrop |Leonard Calabrese
Immunocompromised Patients In RheumatologyKevin WinthropWinthrop first provided an understanding of immunocompromised states in rheumatology, explaining that various diseases and therapeutic interventions contributed to immunodeficiency. Patients with RA on anti-TNF therapy or low-dose steroids, patients with psoriasis taking IL-23 inhibitors, and those with autoantibodies to interferon-γ receptor, will be immunocompromised.
-
Dec 20, 2023 | 
ard.bmj.com | Kevin L. Winthrop |Philip Mease |Andreas Kerschbaumer |Reinhard E. Voll
Handling editor David S PisetskyTwitter @ProfJohnIsaacs, @CarolineOspelt, @StefanSiebert1Contributors All authors contributed to the study design, data collection, discussion and critical revision of the manuscript. Funding The Advances in Targeted Therapies meeting was supported by: AbbVie, AnaptysBio, BMS, Chugai, Eli Lilly, Galapagos, GSK, Janssen, Mitsubishi, Novartis, and Pfizer.
-
May 11, 2023 | 
ard.bmj.com | Marcia Friedman |Kevin L. Winthrop
http://orcid.org/0000-0001-6722-2159Marcia A Friedman1, http://orcid.org/0000-0002-3892-6947Kevin L Winthrop1,2 1 Medicine, Oregon Health & Science University, Portland, Oregon, USA 2 School of Public Health, Oregon Health & Science University, Portland, Oregon, USA Correspondence to Dr Marcia A Friedman, Medicine, Oregon Health & Science University, Portland, OR 97239-3098, USA; friedmam{at}ohsu.edu Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this...
-
Apr 12, 2023 | 
ard.bmj.com | Kevin L. Winthrop |John D Isaacs |Philip Mease |Dimitrios T. Boumpas
http://orcid.org/0000-0002-3892-6947Kevin L Winthrop1, http://orcid.org/0000-0002-6103-7056John D Isaacs2, http://orcid.org/0000-0002-6620-0457Philip J Mease3, http://orcid.org/0000-0002-9812-4671Dimitrios T Boumpas4, http://orcid.org/0000-0002-9475-9362Xenofon Baraliakos5, http://orcid.org/0000-0002-9469-946XJacques-Eric Gottenberg6, http://orcid.org/0000-0002-1802-7311Stefan Siebert7, Marta Mosca8, Neil Basu7, Dana Orange8, R Lories9, http://orcid.org/0000-0003-2108-0030Daniel Aletaha10,...
